Global Paradise System US Post Approval Study (NCT06297291)
The Global Paradise® System US Post Approval Study (US GPS)
🩺 Plain-English Summary (8th-Grade Level)
The objective of the Global Paradise® System US Post Approval Study (US GPS) is to evaluate the real-world use of the Paradise Ultrasound Renal Denervation System indicated for patients who are unable to lower their blood pressure with lifestyle changes and medication. This system is comprised of a catheter, cable, balloon, and generator and has received FDA approval in the United States. Information collected in this study will be analyzed to better understand the long-term safety and effectiveness of treatment with the Paradise System for patients with high blood pressure.
Who can join: Review the eligibility criteria below.
Location: Tibor Rubin VA Medical Center — Long Beach, California
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (43 Sites)
Showing the first 25 of 43 sites.
- Tibor Rubin VA Medical Center — Long Beach, California
- Cedars-Sinai Medical Center — Los Angeles, California
- Sutter Institute for Medical Research — Sacramento, California
- UC Davis Medical Center — Sacramento, California
- Pacific Heart Institute — Santa Monica, California
- Rocky Mountain Regional VAMC — Aurora, Colorado
- Medical Center of the Rockies — Loveland, Colorado
- Bridgeport Hosptial — Bridgeport, Connecticut
- The Cardiac & Vascular Institute — Gainesville, Florida
- University of Miami Health System — Miami, Florida
- Ascension Sacred Heart — Pensacola, Florida
- Tampa Cardiovascular Interventions and Research — Tampa, Florida
- Wellstar Kennestone Hospital — Marietta, Georgia
- Southern Illinois University, Memorial Medical Center — Springfield, Illinois
- Ascension via Christi St. Francis — Wichita, Kansas
- Touro Infirmary — New Orleans, Louisiana
- Massachusetts General Hospital — Boston, Massachusetts
- The Brigham and Women's Hospital — Boston, Massachusetts
- Henry Ford Health — Detroit, Michigan
- Henry Ford St. John Hospital — Detroit, Michigan
- Metropolitan Heart & Vascular Institute — Coon Rapids, Minnesota
- Saint Luke's Mid America Heart Institute — Kansas City, Missouri
- Virtua Health — Marlton, New Jersey
- Albany Medical Center — Albany, New York
- NewYork-Presbyterian Brooklyn Methodist Hospital — Brooklyn, New York
📞 Contact the Study Coordinator
Phone: (650) 912-9032
Email: hreeve-stoffer@recormedical.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Hypertension
- Implementing a Home Blood Pressure Monitoring Program in Primary Care — New York, New York
- SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN — Birmingham, Alabama
- Stress and Blood Pressure Management for Caregivers — Columbus, Ohio
- Caveolin-1 and Vascular Dysfunction — Boston, Massachusetts
- The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension — Birmingham, Alabama
- Skills-Based Educational Strategies for Reduction of Vascular Events in Orange County — Irvine, California
Explore by condition: All Hypertension clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.